Relaxant Actions of α2-Adrenoceptor Agonists in Rat Aorta

α2-Adrenoceptor Agonists의 흰쥐 대동맥 이완 작용

  • Cho, In-gook (Bio-Safety Research Institute, Chonbuk National University) ;
  • Lee, Sang-woo (Bio-Safety Research Institute, Chonbuk National University) ;
  • Kang, Hyung-sub (Bio-Safety Research Institute, Chonbuk National University) ;
  • Seo, Heyng-seok (Chonbuk Livestock and Veterinary Research Institute) ;
  • Kim, Jin-shang (Bio-Safety Research Institute, Chonbuk National University)
  • 조인국 (전북대학교 생체안전성연구소) ;
  • 이상우 (전북대학교 생체안전성연구소) ;
  • 강형섭 (전북대학교 생체안전성연구소) ;
  • 서형석 ;
  • 김진상 (전북대학교 생체안전성연구소)
  • Accepted : 2003.07.10
  • Published : 2003.09.25


The vasorelaxant actions and blood pressure lowering of the ${\alpha}_2$-adrenoceptor agonists (${\alpha}_2$-AAs) clonidine and xylazine were investigated in rat isolated aortic rings and anesthesized rats. Both clonidine and xylazine produced a concentration-dependent inhibition of the sustained contraction induced by norepinephrine (NE), but not by KCl. NE-induced contractions were attenuated partly by nifedipine or verapamil, voltage dependent $Ca^{2+}$ channel blockers. These $Ca^{2+}$ channel blockers-resistant contractions were abolished by clonidine or xylazine. Inhibitory effects of a ${\alpha}_2$-AAs on contractions could be reversed by ryanodine, an intracellular $Ca^{2+}$, transport blocker, and tetrabutylammonium (TBA), a $Ca^{2+}$ activated $K^+$ channel blocker, but not by nifedipine, glibenclamide or removal of extracellular $Ca^{2+}$ and endothelium. Moreover, ${\alpha}_2$-AAs produced relaxation in NE-precontracted isolated intact aortic rings in a concentration-dependent manner, but not in KCl-precontracted rings. The relaxant effects of ${\alpha}_2$-AAs were inhibited by ryanodine and TBA, but not by nifedipine, glibenclamide, N (G)-nitro-L-arginine (L-NNA), N(omega)-nitro-L-arginine methyl ester (L-NAME), aminoguanidine (AG), 2-nitro-4-carboxyphenyl N,N-diphenylcarhurnte (NCDC), lithium sulfate, staurosporine or removal of extracellular $Ca^{2+}$ and endothelium. In vivo, infusion of xylazine elicited significant decrease in anerial blood pressure. This xylazinelowered blood pressure was completely inhibited by the intravenous injection of TBA, but not by the intravenous injection of glibenclamide, L-NNA, L-NAME, AG, nifedipine, lithium sulfate or saponin.. These findings showed that the receptor-mediated and ${\alpha}_2$-adrenoceptor A-stimulated endothelium-independent vasorelaxant effect may be explained by decreasing intracellular $Ca^{2+}$ release and activation of $Ca^{2+}$-activated $K^+$ channels, which may contribute to the hypotensive effects of ${\alpha}_2$-AAs in rats.


  1. Atalik K. E., Sahin A. S. and Dogan N. Interactions between phenylephrine, clonidine and xylazine in rat and rabbit aortas. Methods. Find. Exp. Clin. Pharmacol. 2000, 22, 145-147
  2. Daly, C. J., McGrath, J. C. and Wilson, V. G. Pharmacological analysis of postjunctional alpha- adrenoceptors mediating contractions to (-)-noradrenaline in the rabbit isolated lateral saphenous vein can be explained by interacting responses to simultaneous activation of alpha 1- and alpha Z-adrenoceptors. Br. J. Pharmacol. 1988, 95, 485-500
  3. Dunn, W. R., Daly, C. J., McGrath, J. C. and Wilson, V. G. The effects of nifedipine on alpha 2-adrenoceptor-mediated contractions in several isolated blood vessels from the rabbit. Br. J. Pharmacol. 1991, 103, 1493-1499
  4. Hudgins, P. M. and Weiss, G. B. Differential effects of calcium removal upon vascular smooth muscle contraction induced by norepinephrine, histamine and potassium. J. Pharmacol. Exp. Ther. 1968, 159, 91-97
  5. Iwanaga, S., Shibata, 0., Tsuda, A., Hashimoto, S., Makita, T., Cho, S. and Sumikawa, K. The role of alpha l-adrenoceptors in the clonidine-induced contraction and relaxation of rat aorta. Res. Commun. Mol. Pathol. Pharmacol. 1998, 102, 137-147
  6. Karaki, H., Ozaki, H., Hori, M., Mitsui-Saito, M., Amano, K., Harada, K., Miyamoto, S., Nakazawa, H., Won, K. J. and Sato, K. Calcium movements, distribution, and functions in smooth muscle. Pharmacol. Rev. 1997, 49, 157-230
  7. Klide, A. M., Calderwood, H. W. and Soma, LR. Cardiopulmonary effects of xylazine in dogs. Am. J. Vet. Res. 1975, 36, 931-935
  8. Sunano, S., Li-Bo, Z., Matsuda, K., Sekiguchi, F., Watanabe, H. and Shimamura, K. Endothelium- dependent relaxation by alpha 2-adrenoceptor agonists in spontaneously hypertensive rat aorta. J. Cardiovasc Pharmacol. 1996, 27, 733-739
  9. Velasco, M. and Luchsinger, A. Central Acting Antihypertensive Drugs: Past, Present, and Future. Am. J. Ther. 1995, 2, 255-257
  10. Langer, S. Z., Duval, N. and Massingham, R. Pharmacologic and therapeutic significance of alpha- adrenoceptor subtypes. J. Cardiovasc. Pharmacol. Suppl. 1985, 8(7), S1-8
  11. Chen, D. G., Dai, X. Z., Zimmerman, B. G. and Bache, R. J. Postsynaptic alpha 1- and alpha 2-adrenergic mechanisms in coronary vasoconstriction. J. Cardiovasc. Pharmacol. 1988, 11, 61-67
  12. Bockman, C. S., Jeffries, W. B. and Abel, P. W. Binding and functional characterization of a1pha-2 adrenergic receptor subtypes on pig vascular endothelium. J. Pharmacol. Exp. Ther. 1993, 267, 1126-1133
  13. Moens, Y. The veterinary experience. Bailliere's Clin Anaesthesiol. 2000, 14, 293-304
  14. Green, S. A. and Thurmon, J. C. Xylazine-a review of its pharmacology and its use in veterinary medicine. J. Vet. Pharmacol. Ther. 1988, 11, 295-313
  15. Berridge, M. J. Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse polypho- sphoinositides instead of phosphatidylinositol. Biochem. J. 1983, 212, 849-858
  16. Timmermans, P. B. and van Zwieten, P. A. Vaso- constriction mediated by postsynaptic alpha 2-adrenoceptor stimulation. Naunyn. Schmiedebergs. Arch. Pharmacol. 1980, 313, 17-20
  17. Brayden, J. E. Potassium channels in vascular smooth muscle, Clin. Exp. Pharmacol. Physiol. 1996, 23, 1069- 1076
  18. Langer, S. Z., Cavero, I. and Massingham, R. Recent developments in noradrenergic neurotransmission and its relevance to the mechanism of action of certain antihypertensive agents. Hypertension. 1980, 2, 372-382
  19. Atalik, E. K., Sahin, A. S., Kilic, M. and Dogan, N. Role of the endothelium on the response to adrenoceptor agonists of rabbit aorta during cooling. Fundam. Clin. Pharmacol. 2000, 14, 25-30
  20. Chen, D. G., Dai, X. Z., Zimmerman, B. G. and Bache, R. J. Postsynaptic alpha 1- and alpha 2-adrenergic mechanisms in coronary vasoconstriction. J. Cardiovasc. Pharmacol. 1988, 11, 61-67
  21. Huang, Y., Bourreau, J. P., Chan, H. Y., Lau, C. W., Wong, J. W. and Yao, X. Inhibitory effect of tetrabutylammonium ions on endothelium/nitric oxide- mediated vasorelaxation. Life. Sci. 2001, 69, 1661-1672
  22. Taggar,t M. J., Menice, C. B., Morgan, K. G. and Wray, S. Effect of metabolic inhibition on intracellular CaU, phosphorylation of myosin regulatory light chain and force in rat smooth muscle. J. Physiol. 1997, 499, 485-496
  23. Vo, P. A., Reid, J. J. and Rand, M. J. Attenuation of vasoconstriction by endogenous nitric oxide in rat caudal artery. Br. J. Pharmacol. 1992, 107, 1121-1128
  24. Nakajima, T., Hazama, H., Hamada, E., Wu, S. N., Igarashi, K., Yamashita, T., Seyama, Y., Omata, M. and Kurachi, Y. Endothelin-l and vasopressin activate Ca(2+)-permeab1e non-selective caution channels in aortic smooth muscle cells: mechanism of receptor- mediated $Ca^{2+}$ influx. J. Mol. Cell. Cardiol. 1996, 28, 707-722
  25. Robertson, D., Goldberg, M. R., Tung, C. S., Hollister, A. S. and Robertson, R. M. Use of alpha 2 adrenoreceptor agonists and antagonists in the functional assessment of the sympathetic nervous system. J. Clin. Invest. 1986, 78, 576-581
  26. Kaneko, K. and Sunano, S. Involvement of alpha- adrenoceptors in the endothelium-dependent depression of noradrenaline-induced contraction in rat aorta. Eur. J. Pharmacol. 1993, 240, 195-200
  27. Nomura, S., Sunagane, N., Lee, T. J., Uruno, T. and Kubota, K. Inhibition of alphal-adrenoceptor- mediated contractions in isolated tail arteries and aorta of the rat by a1pha2-adrenoceptor agonists. Res. Commun. Mol. Pathol. Pharmacol. 1995, 90, 307-320
  28. Somlyo, A. P. and Himpens, B. Cell calcium and its regulation in smooth muscle. FASEB. J. 1989, 3, 2266-2276
  29. Wagner, A. E., Muir, W. W. and Hinchcliff, K. W. Cardiovascular effects of xylazine and detomidine in horses. Am. J. Vet. Res. 1991, 52, 651-657
  30. Aantaa, R. $Alpha_2$-adrenoceptor antagonists. Bailliere's Clin. Anaesthesiol. 2000, 14, 285-292
  31. Dabire, H., Chamiot-Clerc, P., Chaouche-Teyara, K., Fournier, B. and Safar, M. E. Acute and chronic sympathoinhibition on carotid artery diameter of spon- taneously hypertensive rats: effects of clonidine and flesinoxan. Clin. Exp. Pharmacol. Physiol. 2000, 27, 715-723
  32. Jinsi, A. and Deth, R. C. Alpha 2-adrenoceptor- mediated vasoconstriction requires a tyrosine kinase. Eur. J. Pharmacol. 1995, 277, 29-34
  33. Carvajal, J. A., Germain, A. M., Huidobro-Toro, J. P. and Weiner, C. P. Molecular mechanism of cGMP-mediated smooth muscle relaxation. J. Cell. Physiol. 2000, 184, 409-420
  34. Faber, J. E. In situ analysis of alpha-adrenoceptors on arteriolar and venular smooth muscle in rat skeletal muscle microcirculation. Circ. Res. 1988, 62, 37-50